Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that often presents significant challenges in both diagnosis and management. This session offers a practical approach to treating HS across its clinical spectrum.

Children with atopic dermatitis don’t all look the same—and neither does their care. This session breaks down how social and cultural factors can shape what you see in clinic and how you treat it.

Drs. Cotton, Okoye, and Weisman will cover high yield practical pearls for caring for pediatric patients with hidradenitis suppurativa (HS).

Chronic hand eczema (CHE) presents a significant clinical challenge due to its multifactorial etiology, impact on quality of life, and recalcitrance to standard therapies for atopic dermatitis. This lecture offers a comprehensive, evidence-based exploration of CHE, emphasizing the differentiation among atopic dermatitis (AD), irritant contact dermatitis (ICD), and allergic contact dermatitis (ACD) - conditions that often overlap in presentation but require distinct management approaches.

This lecture provides an in-depth exploration of cosmetic neurotoxins, focusing on their clinical applications, mechanism of action, and safety considerations. Attendees will gain a comprehensive understanding of how neurotoxins, such as botulinum toxin, work at the neurochemical level.

Burnout doesn't have to be the end of your career - it can be the catalyst for a new beginning. Hope's CPR framework provides a clear, actionable path to help clinicians heal, regain clarity, and confidently map out their next career steps - whether that means reviving your current role or recharting your path.

This lecture provides a thorough exploration of cosmetic fillers and biostimulators, catering to professionals at all levels of experience. Whether you're just starting out or refining your skills, this session will cover the foundational principles and advanced applications of hyaluronic acid injectables and biostimulators such as poly-L-lactic acid and calcium hydroxylapatite.

This session will provide a comprehensive review of its pathogenesis, highlighting the latest evidence on disease burden and associated comorbidities.

Hair loss in patients with skin of color presents unique diagnostic and therapeutic challenges due to variations in hair biology, clinical presentation, and cultural considerations. This session explores the most common types of alopecia seen in patients with skin of color, including central centrifugal cicatricial alopecia (CCCA), traction alopecia, frontal fibrosing alopecia, and androgenetic alopecia.

The past two decades have produced an explosion of new immunotherapies for cutaneous diseases. In this lecture we will discuss the next wave of new treatments being developed. Of particular emphasis will be a discussion of why these newer treatments may be advantageous for our patients and potential pitfalls of new therapies.